MAP1S and prostate cancer: The tumor suppressive function of autophagy regulator MAP1S and its interactive protein LRPPRC has been documented in multiple types of cancers including human ovarian cancer [19], prostate cancer [21, 22], gastric cancer [43] and carcinogen-induced mouse hepatocellular carcinomas [6, 20].